Resource: Update on venous diseases

Covering the latest advancements and findings in venous disease, this resource is the outcome from the RSM’s annual Venous Forum, which focuses on improving the care of patients with venous disease and improving standards for the delivery of healthcare.

Here you will find lectures and key references on the following areas:

  • Controversies in management of superficial venous thrombosis (thrombophlebitis)
  • Progression of venous thrombosis to DVT
  • Venous ulcer management
  • Establishing the correct aetiology and pathology before treating a leg ulcer
  • A national strategy for venous leg ulceration
14 items



Mr Jeremy Perkins, Consultant Vascular Surgeon Oxford University Hospitals NHS Foundation Trust.

Date: 10th July 2017
Free View

Mr. S J Goodyear MD FRCS Consultant Vascular and Endovascular Surgeon, Worcestershire Royal Hospital.

Date: 10th July 2017
Free View

John Vince Smyth Consultant Vascular Surgeon, Manchester Royal Infirmary.

Date: 10th July 2017
Free View

Mark Whyman, Consultant vascular surgeon, Cheltenham Vascular Unit.

Date: 18th September 2017
Free View

Mr Simon Hobbs, Consultant vascuar surgeon, Black Country Vascular Network.

Date: 10th July 2017
Free View

Keith R Poskitt.

Date: 10th July 2017
Free View

Dr Una Adderley PhD, DN, RGN
School of Healthcare, University of Leeds, UK.

Date: 10th July 2017
Free View

Professor Alun H Davies, Imperial College London.

Date: 10th July 2017
Free View

Alison Hopkins, Chief Executive AccelerateCIC.

Date: 10th July 2017
Free View

Claire Judge RGN NIP BEM

Sclerotherapy Specialist Nurse.

Date: 10th July 2017
Free View

Philip Coleridge Smith DM FRCS, Consultant Vascular Surgeon, British Vein Institue, London, UK

President, British Association of Sclerotherapists.

Date: 10th July 2017
Free View

Gareth Bate CNS Vascular Surgery

Heart of England NHS Trust.

Date: 10th July 2017
Free View

Raghu Kolluri, ms, md, rvt, FSVM

System medical director – vascular medicine/ VASCular Labs

Medical director – Ohiohealth vascular core labs

Ohiohealth Vascular institute, columbus, OH.

Date: 10th July 2017
Free View

Key references

All the references listed below are available in the RSM Library collection and can be accessed via the RSM’s e-resources area. [link e-resources to  ]

Di Minno, M. N. D., Ambrosino, P., Ambrosini, F., Tremoli, E., Di Minno, G., and Dentali, F. (2016). Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. Journal of thrombosis and haemostasis: JTH, 14(5), pp. 964-72.

Décousus, H., Bertoletti, L., and Frappé, P. (2015). Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat? Journal of Thrombosis and Haemostasis: JTH, 13 Suppl 1, pp. S230-7.

Baggen, V. J. M., Chung, K., Koole, K., Sarneel, M. H. J., Rutten, F. H., and Hajer, G. R. (2015). Association of varicosities and concomitant deep venous thrombosis in patients with superficial venous thrombosis, a systematic review. European Journal of General Practice, 21(1), pp. 70-76.

Di Nisio, M., Wichers, I. M., and Middeldorp, S. (2013). Treatment for superficial thrombophlebitis of the leg. The Cochrane database of systematic reviews, (4), pp. CD004982. Located in the Cochrane Library:


Galanaud, J. P., Bosson, J. L., Genty, C., Presles, E., Cucherat, M., Sevestre, M. A., Quere, I., Decousus, H., and Leizorovicz, A. (2012). Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies. Journal of Thrombosis and Haemostasis: JTH, 10(6), pp. 1004-11.

Ageno, W., and Dentali, F. (2017). Direct oral anticoagulants for superficial-vein thrombosis. The Lancet Haematology, 4(3), pp. e95-e96.

Beyer-Westendorf, J., Schellong, S. M., Gerlach, H., Rabe, E., Weitz, J. I., Jersemann, K., Sahin, K., and Bauersachs, R. (2017). Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. The Lancet Haematology, 4(3), pp. e105-e113.

Raffetto, J. D., and Eberhardt, R. T. (2015). Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 3(2), pp. 236-241.

Leizorovicz, A., Becker, F., Buchmüller, A., Quéré, I., Prandoni, P., and Decousus, H. (2013). Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood, 122(10), pp. 1724-9.

Cosmi, B., Filippini, M., Tonti, D., Avruscio, G., Ghirarduzzi, A., Bucherini, E., Camporese, G., Imberti, D., and Palareti, G. (2012). A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis: JTH, 10(6), pp. 1026-35.


Rathbun, S. W., Aston, C. E., and Whitsett, T. L. (2012). A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. Journal of Thrombosis and Haemostasis: JTH, 10(5), pp. 833-9.

Decousus, H., Prandoni, P., Mismetti, P., Bauersachs, R. M., Boda, Z., Brenner, B., Laporte, S., Matyas, L., Middeldorp, S., Sokurenko, G., and Leizorovicz, A. (2010). Fondaparinux for the treatment of superficial-vein thrombosis in the legs. New England Journal of Medicine, 363(13), pp. 1222-1232.


External references [as red heading]

The following references are not available in the RSM Library; however they can be accessed online via external websites.

Giannoukas, A. D. (2013). Current management of superficial thrombophlebitis of the lower limb. Phlebolymphology, 20(3), pp. 127-132. Online at: